Fourrts (india) Laboratories Private Limited Mebendazole Export Data — India (DGFT 2022–2026)

Name: Fourrts (india) Laboratories Private Limited Mebendazole Export Records India — #8 Exporter, 18 Shipments, $256.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Mebendazole

India Pharmaceutical Trade Intelligence

$13.7M259 Suppliers108 CountriesHS 30049099

ExportsIndia → CAMEROON22.4%India → FRANCE14.3%

ImportsUNITED STATES → India$347.0K ISRAEL → India$34.0K

#1 Supplier: KROSYL PHARMACEUTICALS #1 Buyer: PLANET PHARMA

Fourrts (india) Laboratories Private Limited — Mebendazole Exporter #8 | $256.0K Trade Value | TransData Nexus | TransData Nexus

Fourrts (india) Laboratories Private Limited — Mebendazole Exporter Profile

Indian Pharmaceutical Exporter · #8 for Mebendazole · $256.0K export value · DGFT Verified

Fourrts (india) Laboratories Private Limited is the #8 Indian exporter of Mebendazole with $256.0K in export value and 18 verified shipments. Fourrts (india) Laboratories Private Limited holds a 1.9% market share in Mebendazole exports across 5 countries. The company exports 17 pharmaceutical products worth $31.5M across 11 therapeutic categories.

Fourrts (india) Laboratories Private Limited — Mebendazole Export Profile: Buyers & Destinations

Fourrts (india) Laboratories Private Limited Mebendazole export treemap — buyers and destination countries | TransData Nexus

Where Does Fourrts (india) Laboratories Private Limited Export Mebendazole?

Country	Value	Shipments	Share
BURKINA FASO	$25.6K	1	100.0%

Fourrts (india) Laboratories Private Limited exports Mebendazole to 1 countries. The largest destination is BURKINA FASO accounting for 100.0% of Fourrts (india) Laboratories Private Limited's Mebendazole shipments. These destinations reflect Fourrts (india) Laboratories Private Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Mebendazole from Fourrts (india) Laboratories Private Limited?

Buyer	Country	Value	Orders

What Mebendazole Formulations Does Fourrts (india) Laboratories Private Limited Export?

Product Description / Formulation	Value	Shipments
MEBENDAZOLE ORAL SUSPENSION QTY 110220X30ML	$25.6K	1

Fourrts (india) Laboratories Private Limited exports 1 distinct Mebendazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MEBENDAZOLE ORAL SUSPENSION QTY 110220X30ML with 1 shipments worth $25.6K.

How Does Fourrts (india) Laboratories Private Limited Compare to Nearest Mebendazole Exporters?

Exporters ranked immediately above and below #8 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	BEID HEALTHCARE PRIVATE LIMITED	$318.2K	40	2	$8.0K
7	J B CHEMICALS PHARMACEUTICALS LIMITED	$313.9K	40	4	$7.8K
8	FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED ★	$256.0K	18	5	$14.2K
9	CADILA PHARMACEUTICALS LTD	$233.7K	5	2	$46.7K
10	MEDOPHARM	$220.3K	34	9	$6.5K

Fourrts (india) Laboratories Private Limited ranks #8 among 259 Indian Mebendazole exporters. Average shipment value of $14.2K compared to the market average of $27.3K. The closest competitors by value are BEID HEALTHCARE PRIVATE LIMITED and J B CHEMICALS PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Mebendazole Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	513	17.5%
SAHAR AIR	450	15.3%
NHAVA SHEVA SEA (INNSA1)	300	10.2%
DELHI AIR CARGO ACC (INDEL4)	289	9.9%
JNPT/ NHAVA SHEVA SEA	170	5.8%
DELHI AIR	162	5.5%
JNPT	130	4.4%
AHEMDABAD ICD	96	3.3%

Geopolitical & Trade Policy Impact on Fourrts (india) Laboratories Private Limited's Mebendazole Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Fourrts. The Israel-Iran conflict has led to disruptions in Middle Eastern trade routes, particularly affecting the Red Sea corridor. Major shipping lines have introduced 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, effectively increasing the cost of exporting pharmaceuticals to key markets. (sgeexport.com)

Conversely, the recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable outlook. The FTA eliminates tariffs on approximately 97% of European exports, including pharmaceuticals, potentially doubling India's exports to the EU by 2032. This development provides Fourrts with an opportunity to expand its footprint in European markets, offsetting challenges in other regions. (en.wikipedia.org)

In the United States, the imposition of tariffs on pharmaceutical imports has prompted a reshoring of manufacturing. While this trend may reduce reliance on Indian generics, it also opens avenues for Indian companies to invest in U.S.-based facilities, thereby maintaining market access. Fourrts could consider strategic investments or partnerships to navigate this evolving landscape. (odrindia.in)

Fourrts (india) Laboratories Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for sustaining export operations. The WHO's alert regarding the 'COLD OUT' syrup underscores the necessity for rigorous quality control and adherence to Good Manufacturing Practices (GMP). Indian pharmaceutical companies are increasingly investing in compliance automation and supply chain restructuring to meet the stringent requirements of markets like the EU and the U.S. (transdatanexus.com)

For Fourrts, maintaining and enhancing compliance protocols is essential to mitigate risks and capitalize on global market opportunities. Proactive engagement with regulatory bodies and continuous improvement in quality assurance processes will be critical in navigating the complex regulatory environment.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Mebendazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Fourrts (india) Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 1 individual customs records matching Fourrts (india) Laboratories Private Limited exporting Mebendazole, covering 1 formulations to 1 countries via 1 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 108+ countries, 756+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Mebendazole

Mebendazole

Fourrts (india) Laboratories Private Limited — Mebendazole Exporter Profile

Fourrts (india) Laboratories Private Limited — Mebendazole Export Profile: Buyers & Destinations

Where Does Fourrts (india) Laboratories Private Limited Export Mebendazole?

Who Are the Top Buyers of Mebendazole from Fourrts (india) Laboratories Private Limited?

What Is India's Total Mebendazole Export Value and How Much Does Fourrts (india) Laboratories Private Limited Contribute?

What Is the Average Shipment Value for Fourrts (india) Laboratories Private Limited's Mebendazole Exports?

How Does Fourrts (india) Laboratories Private Limited Compare to Other Indian Mebendazole Exporters?

What Mebendazole Formulations Does Fourrts (india) Laboratories Private Limited Export?

How Does Fourrts (india) Laboratories Private Limited Compare to Nearest Mebendazole Exporters?

Which Indian Ports Ship Mebendazole Exports?

What Other Antimalarial & Antiparasitic Products Does Fourrts (india) Laboratories Private Limited Export?

Geopolitical & Trade Policy Impact on Fourrts (india) Laboratories Private Limited's Mebendazole Exports

Fourrts (india) Laboratories Private Limited — Regulatory Compliance & Quality Standards

About Fourrts (india) Laboratories Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Mebendazole Export Data from Fourrts (india) Laboratories Private Limited

Mebendazole Stats

Company Overview

Top Products by Fourrts (india) Laboratories Private Limited

Related Analysis

Need Detailed Export Data?

Data Source